Cargando…

Blocking Entry of Hepatitis B and D Viruses to Hepatocytes as a Novel Immunotherapy for Treating Chronic Infections

BACKGROUND: Chronic hepatitis B and D virus (HBV/HDV) infections can cause cancer. Current HBV therapy using nucleoside analogues (NAs) is life-long and reduces but does not eliminate the risk of cancer. A hallmark of chronic hepatitis B is a dysfunctional HBV-specific T-cell response. We therefore...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maravelia, Panagiota, Frelin, Lars, Ni, Yi, Caro Pérez, Noelia, Ahlén, Gustaf, Jagya, Neetu, Verch, Georg, Verhoye, Lieven, Pater, Lena, Johansson, Magnus, Pasetto, Anna, Meuleman, Philip, Urban, Stephan, Sällberg, Matti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781452/ https://www.ncbi.nlm.nih.gov/pubmed/31994701 http://dx.doi.org/10.1093/infdis/jiaa036

Ejemplares similares

Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections
por: Burm, Rani, et al.
Publicado: (2023)

Editorial: HBV—the naked truth?
por: Pasetto, Anna, et al.
Publicado: (2019)

Functional Aspects of Intrahepatic Hepatitis B Virus-specific T Cells Induced by Therapeutic DNA Vaccination
por: Brass, Anette, et al.
Publicado: (2015)

Functional differences in hepatitis C virus nonstructural (NS) 3/4A- and 5A-specific T cell responses
por: Holmström, Fredrik, et al.
Publicado: (2016)

A targeted controlled force injection of genetic material in vivo
por: Ahlén, Gustaf, et al.
Publicado: (2016)

A Heterologous Prime/Boost Vaccination Strategy Enhances the Immunogenicity of Therapeutic Vaccines for Hepatitis C Virus
por: Fournillier, Anne, et al.
Publicado: (2013)

Immune-mediated effects targeting hepatitis C virus in a syngeneic replicon cell transplantation mouse model
por: Levander, Sepideh, et al.
Publicado: (2018)

A small step closer to the Holy Grail of DNA vaccines: undisputed clinical benefit in humans
por: Frelin, Lars, et al.
Publicado: (2009)

Process Development for Adoptive Cell Therapy in Academia: A Pipeline for Clinical-Scale Manufacturing of Multiple TCR-T Cell Products
por: Silva, Daniela Nascimento, et al.
Publicado: (2022)

Liver, Tumor and Viral Hepatitis: Key Players in the Complex Balance Between Tolerance and Immune Activation
por: Sällberg, Matti, et al.
Publicado: (2020)

The SARS-CoV-2 N Protein Is a Good Component in a Vaccine
por: Ahlén, Gustaf, et al.
Publicado: (2020)

Therapeutic DNA Vaccination Using In Vivo Electroporation Followed by Standard of Care Therapy in Patients With Genotype 1 Chronic Hepatitis C
por: Weiland, Ola, et al.
Publicado: (2013)

Cleavage of the IPS-1/Cardif/MAVS/VISA does not inhibit T cell-mediated elimination of hepatitis C virus non-structural 3/4A-expressing hepatocytes
por: Ahlén, G, et al.
Publicado: (2009)

Generation of T-cell receptors targeting a genetically stable and immunodominant cytotoxic T-lymphocyte epitope within hepatitis C virus non-structural protein 3
por: Pasetto, Anna, et al.
Publicado: (2012)

Liquid Biopsy in Hepatocellular Carcinoma: Opportunities and Challenges for Immunotherapy
por: Maravelia, Panagiota, et al.
Publicado: (2021)

Hepatitis C Virus Nonstructural 3/4A Protein Dampens Inflammation and Contributes to Slow Fibrosis Progression during Chronic Fibrosis In Vivo
por: Bansal, Ruchi, et al.
Publicado: (2015)

ATMP development and pre-GMP environment in academia: a safety net for early cell and gene therapy development and manufacturing
por: Silva, D.N., et al.
Publicado: (2022)

A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells
por: Appelberg, Sofia, et al.
Publicado: (2022)

Entry of hepatitis B and hepatitis D virus into hepatocytes: Basic insights and clinical implications
por: Li, Wenhui, et al.
Publicado: (2016)

Hepatitis C virus entry into the hepatocyte
por: Belouzard, Sandrine, et al.
Publicado: (2011)

Robust hepatitis E virus infection and transcriptional response in human hepatocytes
por: Todt, Daniel, et al.
Publicado: (2020)

Study of Hepatitis E Virus-4 Infection in Human Liver-Chimeric, Immunodeficient, and Immunocompetent Mice
por: Collignon, Laura, et al.
Publicado: (2022)

Regulated Entry of Hepatitis C Virus into Hepatocytes
por: Miao, Zhijiang, et al.
Publicado: (2017)

Implementation of a Rapid Entry Program Decreases Time to Viral Suppression Among Vulnerable Persons Living With HIV in the Southern United States
por: Colasanti, Jonathan, et al.
Publicado: (2018)

RNA-Seq Based Transcriptome Analysis of Hepatitis E Virus (HEV) and Hepatitis B Virus (HBV) Replicon Transfected Huh-7 Cells
por: Jagya, Neetu, et al.
Publicado: (2014)

HVR1-mediated antibody evasion of highly infectious in vivo adapted HCV in humanised mice
por: Prentoe, Jannick, et al.
Publicado: (2016)

EGF receptor modulates HEV entry in human hepatocytes
por: Schrader, Jil A., et al.
Publicado: (2023)

Expansion, in vivo–ex vivo cycling, and genetic manipulation of primary human hepatocytes
por: Michailidis, Eleftherios, et al.
Publicado: (2020)

Cerebrospinal Fluid Viral Load Across the Spectrum of Untreated Human Immunodeficiency Virus Type 1 (HIV-1) Infection: A Cross-Sectional Multicenter Study
por: Ulfhammer, Gustaf, et al.
Publicado: (2021)

Preserved Mucosal-Associated Invariant T Cells in the Cervical Mucosa of HIV-Infected Women with Dominant Expression of the TRAV1-2–TRAJ20 T Cell Receptor α-Chain( )
por: Gibbs, Anna, et al.
Publicado: (2022)

A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection
por: Burm, Rani, et al.
Publicado: (2022)

SARS‐CoV‐2‐specific humoral and cellular immunity persists through 9 months irrespective of COVID‐19 severity at hospitalisation
por: Sandberg, John Tyler, et al.
Publicado: (2021)

The inlAB locus mediates the entry of Listeria monocytogenes into hepatocytes in vivo
Publicado: (1996)

Plasmodium Secretion Induces Hepatocyte Lysosome Exocytosis and Promotes Parasite Entry
por: Vijayan, Kamalakannan, et al.
Publicado: (2019)

Human but Not Mouse Hepatocytes Respond to Interferon-Lambda In Vivo
por: Hermant, Pascale, et al.
Publicado: (2014)

Incidence, Etiology, and Outcomes of Community-Acquired Pneumonia: A Population-Based Study
por: Bjarnason, Agnar, et al.
Publicado: (2018)

Transmission of Respiratory Syncytial Virus Infection Within Families
por: Heikkinen, Terho, et al.
Publicado: (2014)

Antibiotic Treatment Duration for Community-Acquired Pneumonia in Outpatient Children in High-Income Countries—A Systematic Review and Meta-Analysis
por: Kuitunen, Ilari, et al.
Publicado: (2022)

Abundance of Noncircular Intrahepatic Hepatitis B Virus DNA May Reflect Frequent Integration Into Human DNA in Chronically Infected Patients
por: Rydell, Gustaf E, et al.
Publicado: (2020)

Molecular determinants of SR-B1-dependent Plasmodium sporozoite entry into hepatocytes
por: Langlois, Anne-Claire, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e5sc9l4l6lgj9eq38nph6931qh